CEPI-Backed Novavax Doses First Patients with COVID-19 Vaccine Candidate
Maryland-based Novavax enrolled and dosed the company’s first patients in a Phase I/II study for a COVID-19 vaccine candidate.
About BioSpace
This author has yet to write their bio.Meanwhile lets just say that we are proud BioSpace contributed a whooping 3627 entries.
Entries by BioSpace
Argenx’s Myasthenia Gravis Drug Shows Positive Results in Late-Stage Trial
Argenx announced positive topline results from the company’s Phase III ADAPT clinical trial of efgartigimod for myasthenia gravis.
WHO Pauses Hydroxychloroquine Arm of COVID-19 Study
Questions over the efficacy and safety of hydroxychloroquine continue to be raised following the World Health Organization’s decision to temporarily halt a study of the malaria drug as a potential treatment for COVID-19.
Merck Takes 3 Major Shots at COVID-19
Merck exploded into the COVID-19 battle with three significant deals and collaborations.
FDA Action Alert: Evofem, Sanofi, Regeneron and Incyte
A look at the U.S. Food and Drug Administration’s drug approval review calendar.
Hot, Humid Weather Slows SARS-CoV-2 Transmission, but Won’t End the Crisis
A hot, humid summer will slow coronavirus transmission but, on its own, is not likely to end the COVID-19 pandemic, according to a new study by researchers at the Massachusetts Institute of Technology, Harvard University, the University of Connecticut and Virginia Tech.
Global fundraising for COVID-19 vaccines, drugs exceeds $10 billion, EU says
A global campaign to fund the development of vaccines and therapies against COVID-19 has so far raised 9.5 billion euros ($10.4 billion), the head of the European Commission said.
CanSino COVID-19 Vaccine Candidate Moves into Phase II
A COVID-19 vaccine candidate under development by China’s CanSino Biologics is moving forward in development after the company published data supporting patient safety.
Research Roundup: Emerging Viral Diseases and More
BioSpace reviews some recently published scientific studies, including researchers with the University of Colorado Anschutz Medical Campus releasing a new study calling attention to the emergence of mosquito-borne viral outbreaks in West Africa.
Biopharma Update on the Novel Coronavirus
Recent updates include the U.S. FDA posting a list of antibody tests that are being withdrawn voluntarily by the test’s commercial manufacturer.